SCHEMBL24676828

SCHEMBL24676828

CC1CC(Nc2ncc(F)c(-c3sc(CO)nc3C(F)(F)F)n2)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.36
DYRK2 Q92630 6/20 0.36
CDK4 P11802 6/20 0.35
CCND1 P24385 6/20 0.35
CCND3 P30281 5/20 0.35
CDK6 Q00534 5/20 0.35
CDK2 P24941 6/20 0.33
CDK1 P06493 5/20 0.33
CCNB1 P14635 4/20 0.33
CCNE1 P24864 3/20 0.33
CCNB2 O95067 1/20 0.33
CCNE2 O96020 1/20 0.33
CDK5 Q00535 1/20 0.33
CDK5R1 Q15078 1/20 0.33
CCNB3 Q8WWL7 1/20 0.33
GPR119 Q8TDV5 1/20 0.33
IDH1 O75874 1/20 0.32
IDH2 P48735 1/20 0.32
CCNT1 O60563 3/20 0.32
CDK9 P50750 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24676928 0.92 CDK4 (0.36) MAPK1DYRK2CDK4CCND1CCND3
SCHEMBL29754914 0.92 CDK4 (0.36) MAPK1DYRK2CDK4CCND1CCND3
SCHEMBL24676477 0.90 MAPK1 (0.36) MAPK1DYRK2CDK4CCND1CCND3
SCHEMBL29754987 0.90 MAPK1 (0.36) MAPK1DYRK2CDK4CCND1CCND3
SCHEMBL24676467 0.90 CCNE1 (0.36) MAPK1DYRK2CDK4CCND1CCND3
SCHEMBL24676598 0.88 DYRK2 (0.44) MAPK1DYRK2CDK4CCND1CCND3
SCHEMBL24676593 0.80 DYRK2 (0.43) MAPK1DYRK2CDK4CCND1CCND3
SCHEMBL24676489 0.79 CDK2 (0.55) CDK4CCND1CCND3CDK6CDK2
SCHEMBL24676591 0.79 DYRK2 (0.41) MAPK1DYRK2CDK4CCND1CCND3
SCHEMBL24676490 0.77 CDK2 (0.37) MAPK1CDK4CCND1CCND3CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022155941-A1 CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2022-07-28 WO disclosed
WO-2022155941-A1 CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2022-07-28 WO disclosed